» Articles » PMID: 23825912

Hedgehog Signaling Pathway and Ovarian Cancer

Overview
Specialty Oncology
Date 2013 Jul 5
PMID 23825912
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Epithelial ovarian carcinoma (EOC) is the most common form of ovarian malignancies and the most lethal gynecologic malignancy in the United States. To date, in spite of treatment to it with the extensive surgical debulking and chemotherapy, the prognosis of EOC remains dismal. Recently, it has become increasingly clear that in many instances, the signaling and molecular players that control development are the same, and when inappropriately regulated, drive tumorigenesis and cancer development. Here, we discuss the possible involvement of Hedgehog (Hh) pathway in the cellular regulation and development of cancer in the ovaries. Using the in vitro and in vivo assays developed has facilitated the dissection of the mechanisms behind Hh-driven ovarian cancers formation and growth. Based on recent studies, we propose that the inhibition of Hh signaling may interfere with spheroid-like structures in ovarian cancers. The components of the Hh signaling may provide novel drug targets, which could be explored as crucial combinatorial strategies for the treatment of ovarian cancers.

Citing Articles

Triptolide inhibits epithelial ovarian tumor growth by blocking the hedgehog/Gli pathway.

Hu L, Gao M, Jiang H, Zhuang L, Jiang Y, Xie S Aging (Albany NY). 2023; 15(20):11131-11151.

PMID: 37851362 PMC: 10637820. DOI: 10.18632/aging.205110.


Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches.

Lucic I, Kurtovic M, Mlinaric M, Pitesa N, cipak Gasparovic A, Sabol M Int J Mol Sci. 2023; 24(13).

PMID: 37445860 PMC: 10342190. DOI: 10.3390/ijms241310683.


New insight into the role of PTCH1 protein in serous ovarian carcinomas.

Karin-Kujundzic V, Covarrubias-Pinto A, Skrtic A, Vranic S, Serman L Int J Oncol. 2022; 61(6).

PMID: 36205138 PMC: 9581113. DOI: 10.3892/ijo.2022.5435.


Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.

Mani C, Tripathi K, Chaudhary S, Somasagara R, Rocconi R, Crasto C Neoplasia. 2021; 23(9):1002-1015.

PMID: 34380074 PMC: 8361230. DOI: 10.1016/j.neo.2021.06.010.


Inhibition of CAL27 Oral Squamous Carcinoma Cell by Targeting Hedgehog Pathway With Vismodegib or Itraconazole.

Freitas R, Dias R, Vidal M, de Faro Valverde L, Gomes Alves Costa R, Damasceno A Front Oncol. 2020; 10:563838.

PMID: 33312948 PMC: 7703359. DOI: 10.3389/fonc.2020.563838.


References
1.
Tang S, Fu J, Nall D, Rodova M, Shankar S, Srivastava R . Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Int J Cancer. 2011; 131(1):30-40. PMC: 3480310. DOI: 10.1002/ijc.26323. View

2.
Svard J, Heby-Henricson K, Henricson K, Persson-Lek M, Rozell B, Lauth M . Genetic elimination of Suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway. Dev Cell. 2006; 10(2):187-97. DOI: 10.1016/j.devcel.2005.12.013. View

3.
Vokes S, Ji H, Wong W, McMahon A . A genome-scale analysis of the cis-regulatory circuitry underlying sonic hedgehog-mediated patterning of the mammalian limb. Genes Dev. 2008; 22(19):2651-63. PMC: 2559910. DOI: 10.1101/gad.1693008. View

4.
Yauch R, Gould S, Scales S, Tang T, Tian H, Ahn C . A paracrine requirement for hedgehog signalling in cancer. Nature. 2008; 455(7211):406-10. DOI: 10.1038/nature07275. View

5.
Mazumdar T, DeVecchio J, Agyeman A, Shi T, Houghton J . The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer. Oncotarget. 2011; 2(8):638-45. PMC: 3248207. DOI: 10.18632/oncotarget.310. View